Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Praxis Precision Medicines discovers sodium channel protein type 8 subunit alpha blockers

Sep. 3, 2018

Invictus Oncology patents CSF1R inhibitors

Sep. 3, 2018

Capella BioSience describes antibodies targeting LIGHT

Sep. 3, 2018

Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors

Aug. 31, 2018

Astellas Pharma discloses KRAS Gly12Cys mutant inhibitors

Aug. 30, 2018

TGF-beta decoy receptors patented by Tessa Therapeutics

Aug. 29, 2018

Biogen describes new mitogen-activated protein kinase kinase kinase 5 inhibitors

Aug. 29, 2018

Aryl hydrocarbon receptor antagonists discovered at Phenex Pharmaceuticals

Aug. 28, 2018

Shire Human Genetic Therapies patents TGF-beta inhibitors

Aug. 28, 2018

Mutabilis SAS synthesizes prodrugs of beta-lactamase inhibitors

Aug. 28, 2018

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...